* Hologic Inc HOLX.OQ HOLX.O is expected to show a rise
in
quarterly revenue when it reports results on July 29 for the
period ending June 30 2024
* The Marlborough Massachusetts-based company is expected
to
report a 1.6% increase in revenue to $1 billion from $984.4
million a year ago, according to the mean estimate from 14
analysts, based on LSEG data.The company's guidance on May 2
2024, for the period ended June 30, was for revenue between
$992.50 million and $1.01 billion.
* LSEG's mean analyst estimate for Hologic Inc is for
earnings of
$1.02 per share. The company's EPS guidance on May 2 2024, for
the period ended June 30, was between $0.98 and $1.05
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," 8
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Hologic Inc
is
$86.50, above its last closing price of $77.88.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Mar. 31 2024 0.98 0.98 1.03 Beat 5.4
Dec. 31 2024 0.97 0.95 0.98 Beat 3
Sep. 30 2023 0.85 0.84 0.89 Beat 5.9
Jun. 30 2023 0.90 0.89 0.93 Beat 4.4
Mar. 0.88 0.88 1.06 Beat 20.2
31 2023
Dec. 31 2022 0.96 0.91 1.07 Beat 17.7
Sep. 30 2022 0.63 0.62 0.82 Beat 31.2
Jun. 30 2022 0.71 0.71 0.95 Beat 33.7
This summary was machine generated July 26 at 20:23 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)